These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1405364

  • 1. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF, St Peter JV, Kasiske BL.
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [Abstract] [Full Text] [Related]

  • 2. [Disturbances of lipid metabolism during nephrotic syndrome: physiopathology and treatment].
    Moulin B, Ollier J, Olmer M.
    Nephrologie; 1992 Oct; 13(5):193-9. PubMed ID: 1470293
    [Abstract] [Full Text] [Related]

  • 3. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P.
    Acta Med Croatica; 2001 Oct; 55(4-5):177-86. PubMed ID: 12398021
    [Abstract] [Full Text] [Related]

  • 4. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P, Reiner Z, Brunetta B.
    Lijec Vjesn; 2002 Oct; 124(11-12):372-7. PubMed ID: 12679979
    [Abstract] [Full Text] [Related]

  • 5. The hyperlipidemia of the nephrotic syndrome.
    Appel GB, Valeri A, Appel AS, Blum C.
    Am J Med; 1989 Nov; 87(5N):45N-50N. PubMed ID: 2486547
    [Abstract] [Full Text] [Related]

  • 6. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M, Anarat A, Bayazit AK, Noyan A, Ozel A, Anarat R, Aydingülü H, Dikmen N.
    Turk J Pediatr; 2002 Nov; 44(1):40-4. PubMed ID: 11858378
    [Abstract] [Full Text] [Related]

  • 7. Dietary cholesterol induced changes in lipid profile in patients with nephrotic syndrome and chronic renal failure.
    Jain PK, Arora RC, Agarwal N, Garg RK, Arora S, Gurbaxani RK, Sharma D.
    J Assoc Physicians India; 1991 Oct; 39(10):751-3. PubMed ID: 1816199
    [Abstract] [Full Text] [Related]

  • 8. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL, Packard CJ.
    Miner Electrolyte Metab; 1993 Oct; 19(3):115-26. PubMed ID: 8232098
    [Abstract] [Full Text] [Related]

  • 9. [Carotid artery thrombosis and myocardial infarction in nephrotic syndrome].
    Nigond J, Grolleau-Raoux R.
    Arch Mal Coeur Vaiss; 1990 Jan; 83(1):105-8. PubMed ID: 2106297
    [Abstract] [Full Text] [Related]

  • 10. Rationale and management of hyperlipidemia of the nephrotic syndrome.
    Grundy SM, Vega GL.
    Am J Med; 1989 Nov; 87(5N):3N-11N. PubMed ID: 2486542
    [Abstract] [Full Text] [Related]

  • 11. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO, Agbedana EO, Kadiri S, Taylor GO.
    Afr J Med Med Sci; 1999 Nov; 28(1-2):97-100. PubMed ID: 12953996
    [Abstract] [Full Text] [Related]

  • 12. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995 Nov; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 13. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.
    Kaysen GA.
    Miner Electrolyte Metab; 1992 Nov; 18(2-5):212-6. PubMed ID: 1465061
    [Abstract] [Full Text] [Related]

  • 14. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA.
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [Abstract] [Full Text] [Related]

  • 15. Statins and diabetes.
    Carmena R, Betteridge DJ.
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [Abstract] [Full Text] [Related]

  • 16. Plasma lipid alterations in patients with chronic renal disease.
    Cramp DG.
    Crit Rev Clin Lab Sci; 1982 Nov; 17(1):77-101. PubMed ID: 6749432
    [Abstract] [Full Text] [Related]

  • 17. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Breier C, Lisch HJ, Drexel H, Braunsteiner H.
    Schweiz Med Wochenschr; 1983 Jun 25; 113(25):909-13. PubMed ID: 6612272
    [Abstract] [Full Text] [Related]

  • 18. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN.
    Miner Electrolyte Metab; 1993 Jun 25; 19(3):127-36. PubMed ID: 8232099
    [Abstract] [Full Text] [Related]

  • 19. Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment.
    Wheeler DC, Bernard DB.
    Am J Kidney Dis; 1994 Mar 25; 23(3):331-46. PubMed ID: 8128933
    [Abstract] [Full Text] [Related]

  • 20. Should hyperlipidemia in children with the nephrotic syndrome be treated?
    Querfeld U.
    Pediatr Nephrol; 1999 Jan 25; 13(1):77-84. PubMed ID: 10100296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.